Irofin-XT Oral Suspension is a pharmaceutical formulation containing Ferrous Ascorbate 30 mg and Folic Acid 0.5 mg per dose, designed to address iron deficiency anemia and folate deficiency. Ferrous Ascorbate serves as a bioavailable source of elemental iron, essential for hemoglobin synthesis and oxygen transport in the bloodstream, while Folic Acid is crucial for DNA synthesis, red blood cell formation, and preventing neural tube defects during pregnancy. This combination is particularly beneficial in treating nutritional anemia caused by inadequate dietary intake, malabsorption, or increased physiological demands such as pregnancy, lactation, and growth phases in children. The oral suspension form facilitates ease of administration and improved compliance, especially in pediatric and geriatric populations who may have difficulty swallowing tablets. Irofin-XT should be administered as per physician’s instructions, with dosage adjusted according to the severity of anemia and individual patient requirements. Common side effects may include gastrointestinal discomfort such as nausea, constipation, or diarrhea, which can often be mitigated by taking the suspension with food. Regular monitoring of hemoglobin levels and iron status is recommended during prolonged therapy to avoid iron overload. This product should be stored in a cool, dry place, protected from light, and kept out of reach of children.